Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
Title | Phase 1/2, First-in-Human, Dose-Escalation Study of X-396 in Patients With Advanced Solid Tumors and Expansion Phase in Patients With ALK-positive Non-Small Cell Lung Cancer |
---|---|
Disease/Condition | Lung Cancer,Solid Tumor |
Eligibility Criteria | Ages Eligible for Study: 18 Years and older Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements |
Principal Investigator | Haiying Cheng, MD |
Contact Name | Karen Fehn |
Phone | (718) 405-8446 |
Contact Email | CPDMUtrialinfo@montefiore.org |
IRB/Protocol Number | IRB# 150617101 |
Status | Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |